Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for FSD PHARMA (HUGE : NSDQ)
 
 • Company Description   
FSD Pharma Inc. produces medical cannabis primarily in Canada. The company focuses on the development of indoor pharmaceutical grade cannabis; research and development of cannabinoid-based treatments for central nervous system disorders. FSD Pharma Inc. is based in Seattle, Washington.

Number of Employees: 10

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.90 Daily Weekly Monthly
20 Day Moving Average: 88,373 shares
Shares Outstanding: 40.42 (millions)
Market Capitalization: $36.38 (millions)
Beta: 0.52
52 Week High: $2.25
52 Week Low: $0.80
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -12.62% -1.60%
12 Week 2.27% 12.43%
Year To Date -11.76% 10.49%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
FIRST CANADIAN PLACE 100 KING STREET WEST SUITE 4000
-
TORONTO,A6 M5X 1A4
CAN
ph: 416-854-8884
fax: -
ir@fsdpharma.com http://www.fsdpharma.com
 
 • General Corporate Information   
Officers
Anthony Durkacz - Interim CEO; Co-Executive Chairman and Director
Zeeshan Saeed - President; Co-Executive Chairman and Director
Donal Carroll - Chief Operating Officer
Adnan Bashir - Director
Fernando Cugliari - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 35954B206
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/11/22
Share - Related Items
Shares Outstanding: 40.42
Most Recent Split Date: 10.00 (0.01:1)
Beta: 0.52
Market Capitalization: $36.38 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/11/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.78
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: 60.00%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -54.70
12/31/21 - -56.31
09/30/21 - -56.87
ROA
03/31/22 - -46.92
12/31/21 - -49.11
09/30/21 - -49.70
Current Ratio
03/31/22 - 4.47
12/31/21 - 5.28
09/30/21 - 5.89
Quick Ratio
03/31/22 - -
12/31/21 - 5.28
09/30/21 - 5.89
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - 1.16
12/31/21 - 1.34
09/30/21 - 1.49
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©